Clinical Trial Update: Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin. [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating valganciclovir prophylaxis in CMV-seropositive kidney transplant patients to influence thymoglobulin-induced CD8+ CMV-specif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Kidney Transplant Infection

Drugs mentioned

• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Kidney Transplant Infection | Phase 3 | Status: COMPLETED